Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Salestools Logo

Salestools

Der #1 KI-Agent für Vertriebsteams und Go-to-Market-Teams. Verkaufen Sie mehr, schneller, mit weniger Aufwand.

Produkt

  • KI-Vertriebsagenten
  • Intent-Daten
  • Technologiedaten
  • Besucher-Tracking
  • Co-Pilot
  • Social Selling

Lösungen

  • Kundenservice
  • E-Commerce
  • SaaS
  • Enterprise
  • Kleinunternehmen

Ressourcen

  • Der Report
  • Dokumentation
  • API-Referenz
  • Hilfecenter
  • Blog
  • Fallstudien
  • Webinare

Unternehmen

  • Über uns
  • Karriere
  • Presse
  • Kontakt
  • Partner

Unsere Standorte

  • New York, HQ
  • Bukarest, KI-Forschungslabor
  • Zug, Schweiz

© 2025 Salestools. Alle Rechte vorbehalten.

Datenbedingungen & SicherheitDatenschutzerklärungNutzungsbedingungen
Alle Systeme betriebsbereit
Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Back to The Report
MedTech

CMR Surgical

CMR Surgical raises $200M Series D at $3B valuation

$200M
Total Raised
Series D
Latest Round
2014
Founded
600+
Employees
Cambridge, UK
Updated April 15, 2025
1 min read

Quick Facts

Valuation
$3B
Latest Round Size
$200M
Latest Round Date
April 2025

CMR Surgical: Series D Funding Round

CMR Surgical has successfully raised $200M in Series D funding, reaching a valuation of $3B.

Company Overview

Surgical robotic systems

Funding Details

The Series D round was led by SoftBank Vision Fund, with participation from LGT.

Company Information

  • Headquarters: Cambridge, UK
  • Founded: 2014
  • Employees: 600+
  • Category: MedTech

Investment

CMR Surgical plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • SoftBank Vision Fund: Verified investor in Series D
  • LGT: Verified investor in Series D

Key Investors

SoftBank Vision Fund
Lead Investor
Verified investor in Series D
LGT
Investor
Verified investor in Series D

Topics

verified(3079)real-funding(3079)cmr-surgicalmedtechseries-dcambridge

About the Author

Editorial Team
Editorial Team
Curated funding news from verified sources

Related Company Reports

MedTech
Galvenize Therapeutics

Galvenize Therapeutics Raises $100M Series C to Transform MedTech

Galvenize Therapeutics has secured $100M Series C in funding to accelerate growth and innovation in the medtech sector. Medical device company developing pulsed electric field therapies for cardiac ablation and tumor treatment...

David Chen
David Chen
Oct 22, 2025
0 min read•$100M Series C
MedTech
Reprieve Cardiovascular

Reprieve Cardiovascular Raises $61M Series B to Transform MedTech

Reprieve Cardiovascular has secured $61M Series B in funding to accelerate growth and innovation in the medtech sector. Cardiovascular device company developing personalized heart failure therapies and monitoring solutions...

David Chen
David Chen
Oct 22, 2025
0 min read•$61M Series B
MedTech
ViCentra

ViCentra Raises $85M Series D to Transform MedTech

ViCentra has secured $85M Series D in funding to accelerate growth and innovation in the medtech sector. Medical device company developing innovative insulin patch pumps for diabetes management...

Sarah Kim
Sarah Kim
Oct 22, 2025
0 min read•$85M Series D